A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT01688206 · COMPLETED
Trial details
- NCT number
- NCT01688206
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-31
- Primary completion
- 2016-12-02
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.